ESR1 and triple-negative breast carcinoma: BC displays high heterogeneity and classifies into four subtypes based on immunohistochemical features: Estrogen receptor positive (ER +); progesterone receptor positive (PR +); human epidermal growth factor receptor positive (HER2 +); and triple negative breast cancer (TNBC) in which none of the previous receptors are expressed [2, 3].